An international team led by a former UBC postdoctoral fellow in medical genetics has uncovered…
pthomsonJanuary 26, 2022
For the past three decades, myeloid malignancies such as myelodysplastic syndrome (MDS) and acute myeloid…
pthomsonJanuary 25, 2022
Sarcomas are cancers of mesenchymal origin with the potential to arise in diverse anatomic locations.…
pthomsonJanuary 25, 2022
This week, we profile a publication in Cell Reports Methods from Vincent Hanlon (pictured) and…
pthomsonJanuary 24, 2022
The health of the communities we live in relies on well functioning ecosystems that provide…
pthomsonJanuary 24, 2022
Solid tumour perfusion can be unstable, creating transiently hypoxic cells that can contribute to radiation…
pthomsonJanuary 21, 2022
Working with a shared voice can be very effective for improving outcomes in the Movement…
sciencecityMay 1, 2017
People with multiple sclerosis can show signs of something wrong five years before the onset…
sciencecityApril 27, 2017
A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering…
sciencecityApril 25, 2017
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development…
sciencecityApril 24, 2017
Researchers have obtained an unprecedented view of the ‘ballistic’ weaponry of planktonic microbes, including one…
sciencecityApril 21, 2017
Hundreds of people are expected to march in Vancouver this Saturday to celebrate the role of…
sciencecityApril 21, 2017
Zymeworks Inc. (“Zymeworks”), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of…
sciencecityApril 21, 2017
Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced…
sciencecityApril 19, 2017
